Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Full IRB Study Title:
ADVL1513: A Phase 1 Study of Entinostat, an Oral Histone Deacetylase Inhibitor, in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
IRB Study ID: 1042403-1
For complete information, please view the study on clinicaltrials.gov.
This study is being done in collaboration with Cincinnati Children's Hospital.
